- Home
- SGBX vs SNPX Comparison
SGBX vs SNPX Comparison
Compare SGBX & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- SNPX
- Stock Information
- Founded
- SGBX 2007
- SNPX 2012
- Country
- SGBX United States
- SNPX United States
- Employees
- SGBX N/A
- SNPX N/A
- Industry
- SGBX RETAIL: Building Materials
- SNPX Medicinal Chemicals and Botanical Products
- Sector
- SGBX Consumer Discretionary
- SNPX Health Care
- Exchange
- SGBX Nasdaq
- SNPX Nasdaq
- Market Cap
- SGBX 2.7M
- SNPX 3.1M
- IPO Year
- SGBX 2017
- SNPX N/A
- Fundamental
- Price
- SGBX $1.10
- SNPX $2.52
- Analyst Decision
- SGBX
- SNPX Strong Buy
- Analyst Count
- SGBX 0
- SNPX 1
- Target Price
- SGBX N/A
- SNPX $14.00
- AVG Volume (30 Days)
- SGBX 10.9M
- SNPX 11.1K
- Earning Date
- SGBX 06-10-2025
- SNPX 05-15-2025
- Dividend Yield
- SGBX N/A
- SNPX N/A
- EPS Growth
- SGBX N/A
- SNPX N/A
- EPS
- SGBX N/A
- SNPX N/A
- Revenue
- SGBX $4,976,618.00
- SNPX N/A
- Revenue This Year
- SGBX $1,628.82
- SNPX N/A
- Revenue Next Year
- SGBX N/A
- SNPX N/A
- P/E Ratio
- SGBX N/A
- SNPX N/A
- Revenue Growth
- SGBX N/A
- SNPX N/A
- 52 Week Low
- SGBX $0.30
- SNPX $1.84
- 52 Week High
- SGBX $4.15
- SNPX $5.05
- Technical
- Relative Strength Index (RSI)
- SGBX 71.88
- SNPX 56.39
- Support Level
- SGBX $0.40
- SNPX $2.12
- Resistance Level
- SGBX $1.45
- SNPX $2.48
- Average True Range (ATR)
- SGBX 0.17
- SNPX 0.20
- MACD
- SGBX 0.08
- SNPX 0.02
- Stochastic Oscillator
- SGBX 66.73
- SNPX 85.89
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.